Kazuto Matsunaga Selected Research

Biological Products

1/2022

Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuto Matsunaga Research Topics

Disease

31	Asthma (Bronchial Asthma) 01/2022 - 07/2006
22	Inflammation (Inflammations) 08/2022 - 09/2006
20	Chronic Obstructive Pulmonary Disease (COPD) 08/2020 - 09/2007
4	Infections 01/2019 - 01/2002
4	Virus Diseases (Viral Diseases) 07/2015 - 06/2009
3	Dyspnea (Shortness of Breath) 01/2019 - 01/2014
3	Legionnaires' Disease (Legionnaire's Disease) 01/2004 - 01/2002
2	Neoplasms (Cancer) 04/2022 - 01/2022
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 08/2012
2	Rhinosinusitis 04/2020 - 01/2018
2	Tuberculosis (Tuberculoses) 10/2019 - 09/2018
2	Rhinitis 01/2017 - 09/2011
2	Allergic Rhinitis 03/2014 - 03/2009
2	Atherosclerosis 07/2012 - 04/2012
2	Bacterial Infections (Bacterial Infection) 01/2004 - 07/2002
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2002 - 01/2002
1	Aspiration Pneumonia 10/2022
1	Organizing Pneumonia 08/2022
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 04/2022
1	Shock 04/2022
1	Thymoma (Thymic Carcinoma) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Granuloma 01/2022
1	Otitis Media 01/2022
1	Sinusitis 01/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022
1	Pneumonia (Pneumonitis) 09/2021
1	Frailty 08/2021
1	Disease Progression 01/2021
1	Anemia 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 04/2020
1	Nasal Polyps (Nasal Polyp) 04/2020
1	Vascular Skin Diseases 12/2019
1	Parasitic Diseases (Parasitic Disease) 10/2019
1	Bronchiectasis 10/2019
1	Chronic Bronchitis 01/2019
1	Cryptococcosis 01/2019
1	Heart Failure 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2017

Drug/Important Bio-Agent (IBA)

22	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2022 - 12/2010
17	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021 - 09/2006
7	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2007
7	SteroidsIBA 01/2020 - 09/2006
6	Immunoglobulin E (IgE)IBA 01/2021 - 01/2011
5	CytokinesIBA 01/2021 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2003
4	Bronchodilator Agents (Bronchodilators)IBA 01/2020 - 01/2015
4	SmokeIBA 10/2019 - 07/2002
4	GoldIBA 01/2018 - 12/2013
3	25-hydroxycholesterolIBA 05/2013 - 04/2012
3	CholesterolIBA 05/2013 - 04/2012
2	Interleukin-5 (Interleukin 5)IBA 01/2022 - 01/2018
2	AntigensIBA 09/2021 - 01/2019
2	InterleukinsIBA 01/2021 - 01/2002
2	Tiotropium Bromide (Spiriva)FDA Link 01/2019 - 01/2011
2	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 09/2013
2	Double-Stranded RNA (RNA, Double Stranded)IBA 07/2015 - 06/2010
2	Toll-Like Receptor 3IBA 07/2015 - 06/2010
2	Carbon MonoxideIBA 12/2013 - 04/2012
2	Interleukin-8 (Interleukin 8)IBA 07/2012 - 09/2007
2	Interleukin-6 (Interleukin 6)IBA 07/2012 - 07/2002
2	Chemokine CCL5IBA 03/2009 - 01/2009
2	Interleukin-12 (IL 12)IBA 11/2003 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2002 - 01/2002
1	polyglucosanIBA 10/2022
1	galactomannanIBA 10/2022
1	AnticoagulantsIBA 04/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2021
1	Interleukin-13IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2021
1	Growth Differentiation Factor 15IBA 08/2020
1	dupilumabIBA 04/2020
1	ciclesonide FDA Link 01/2020
1	osimertinibIBA 12/2019
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 03/2019
1	Procaterol (Pro-Air)IBA 03/2019
1	aclidinium bromideIBA 01/2019
1	MacrolidesIBA 01/2019
1	Antifibrotic AgentsIBA 01/2019
1	RoflumilastIBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2018
1	anti-IgE antibodiesIBA 01/2018
1	Pharmaceutical PreparationsIBA 08/2017

Therapy/Procedure

12	Therapeutics 09/2021 - 09/2006
2	Radiotherapy 04/2022 - 01/2021
2	Biological Therapy 01/2022 - 01/2018
1	Hematopoietic Stem Cell Transplantation 08/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Neoadjuvant Therapy 04/2022
1	Hemoperfusion 01/2022
1	Chemoradiotherapy 01/2021